rs397516015
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_000256.3(MYBPC3):c.3323A>C(p.Lys1108Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000949 in 1,602,334 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.3323A>C | p.Lys1108Thr | missense_variant | Exon 30 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.3323A>C | p.Lys1108Thr | missense_variant | Exon 29 of 34 | 5 | ENSP00000382193.2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152154Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000394 AC: 9AN: 228198Hom.: 0 AF XY: 0.0000243 AC XY: 3AN XY: 123592
GnomAD4 exome AF: 0.0000938 AC: 136AN: 1450180Hom.: 0 Cov.: 34 AF XY: 0.0000875 AC XY: 63AN XY: 720090
GnomAD4 genome AF: 0.000105 AC: 16AN: 152154Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74322
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy Uncertain:2
This sequence change replaces lysine, which is basic and polar, with threonine, which is neutral and polar, at codon 1108 of the MYBPC3 protein (p.Lys1108Thr). This variant is present in population databases (rs397516015, gnomAD 0.01%). This missense change has been observed in individual(s) with arrhythmia and dilated cardiomyopathy, hypertrophic cardiomyopathy, as well as in one individual without cardiomyopathy from the Framingham Offspring Study participants (PMID: 22958901, 26743238, 32746448, 37652022). ClinVar contains an entry for this variant (Variation ID: 42704). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This missense variant replaces lysine with threonine at codon 1108 of the MYBPC3 protein. Computational prediction tools indicate that this variant has a neutral impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in one individual affected with hypertrophic cardiomyopathy (PMID: 33495597), in one individual affected with arrhythmia (PMID: 26743238), and in one individual affected with dilated cardiomyopathy (PMID: 32746448). This variant has been identified in 16/259538 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The Lys1108Thr variant (MYBPC3) has not been reported in the literature nor previously identifi ed in >2000 Caucasian probands tested by our laboratory. Lysine (Lys) at postion 1108 is highly conserved through distantly related species and computational an alyses (biochemical amino acid properties, AlignGVGD, PolyPhen2, and SIFT) sugge st that the Lys1108Thr variant may impact the protein, though this information i s not predictive enough to determine pathogenicity. Although this data supports that the Lys1108Thr variant may be pathogenic, additional studies are needed to fully assess its clinical significance. -
Hypertrophic cardiomyopathy 4;C3715165:Left ventricular noncompaction 10 Uncertain:1
- -
Cardiomyopathy Uncertain:1
This missense variant replaces lysine with threonine at codon 1108 of the MYBPC3 protein. Computational prediction tools indicate that this variant has a neutral impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in one individual affected with hypertrophic cardiomyopathy (PMID: 33495597), in one individual affected with arrhythmia (PMID: 26743238), and in one individual affected with dilated cardiomyopathy (PMID: 32746448). This variant has been identified in 16/259538 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Reported in individuals with HCM, sudden unexplained death and/or DCM in published literature and in patients referred to GeneDx for genetic testing; however clinical details and segregation studies are not available for the published cases (PMID: 29247119, 26743238, 32746448); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26743238, 22958901, 28679633, 32746448, 29247119, 35653365, 37652022) -
Cardiovascular phenotype Uncertain:1
The p.K1108T variant (also known as c.3323A>C), located in coding exon 30 of the MYBPC3 gene, results from an A to C substitution at nucleotide position 3323. The lysine at codon 1108 is replaced by threonine, an amino acid with similar properties. This variant has been reported in an arrhythmia cohort and a sudden unexplained death case; however, clinical details were limited (Adler A et al. Circ Arrhythm Electrophysiol, 2016 Jan;9:e003440; Lin Y et al. Circ Cardiovasc Genet, 2017 Dec;10:). This alteration has also been reported in a population-based longitudinal study in an individual without overt cardiomyopathy (Bick AG et al. Am. J. Hum. Genet., 2012 Sep;91:513-9). This alteration has been reported in association with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM); however, clinical data is limited and it was also reported in a control individual (Helms AS et al. Circ Genom Precis Med, 2020 Oct;13:396-405; Tadros R et al. Nat Genet, 2021 Feb;53:128-134; Burstein DS et al. Pediatr Res, 2021 May;89:1470-1476; Stava TT et al. Eur J Prev Cardiol, 2022 Oct;29:1789-1799). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at